NCT05573308 Optimizing Orthodontic Appliances Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms
| NCT ID | NCT05573308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Malocclusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2022-10-17 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2022-10-17 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The decision on aligner changing is based on orthodontists' personal experience and common knowledge that an approximated time span for the aligner have exhausted its biological efficacy. However, a one size fits all approach is not always ideal, as an average determined time is not taken into account of a patient's individual biological response. The aligners could be progressed earlier than the determined time, or they may stay inactive for a while, waiting for the in-office visit. Dental MonitoringTM is the only available technology that provides 3D monitoring of teeth movement, reconstructs 3D digital models remotely, and auto-detect clinical situations by their patented AI algorithms. The investigators have reported high accuracy of DMTM to monitor the tooth movement in vitro. However, the efficacy of DMTM on orthodontic treatment and the accuracy of DMTM in the orthodontic patients has not been investigated yet. In this proposal, the investigators are implementing the Dental MonitoringTM application and 3D tracking of tooth movement powered by AI algorisms as a novel tool to customize aligner changing intervals. The ultimate goal is to reduce in-office visits and treatment duration while maintaining regular monitoring, thus not jeopardizing expected results. It is imperative to investigate the Teledentistry for its effectiveness, reliability, ease of use, patient satisfaction, and value on the overall health and oral health system, especially as a critical tool during public health emergency situations.
Eligibility Criteria
Inclusion Criteria: * Patients who request clear aligner treatment with the sole aim of correcting dental alignment. * Patients must be 12 years old or older. * Complete permanent dentition (excluding third molars). * Non-extraction treatment, * Upper or lower labial segment crowding. malocclusion to be treated with more than 20 Clear Aligners. Exclusion Criteria: * Patients with systematic diseases or syndromes * Patients with a history or current use of Bisphosphonates * Patients with current use of nonsteroidal anti-inflammatory drugs (NSAIDs) * Active periodontal disease * Presence of dental prostheses, * The presence of dental anomalies (7) The treatment combined with fixed appliances or other auxiliary appliances.
Frequently Asked Questions
Who can join the NCT05573308 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 70 Years, studying Malocclusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05573308 currently recruiting?
Yes, NCT05573308 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Illinois at Chicago to inquire about joining.
Where is the NCT05573308 trial being conducted?
This trial is being conducted at Antioch, United States, Chicago, United States, Grayslake, United States, Gurnee, United States.
Who is sponsoring the NCT05573308 clinical trial?
NCT05573308 is sponsored by University of Illinois at Chicago. The trial plans to enroll 12 participants.